BME NITINOL CONTINUOUS COMPRESSION IMPLANTS: payments to doctors
Payments that named BME NITINOL CONTINUOUS COMPRESSION IMPLANTS as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $164K
- Providers
- 2,091
- Transactions
- 3,023
- Average per transaction
- $54
The per-transaction average — $54 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,091 providers the average total is $78, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $150,623 | 92.0% |
| Medical Device Business Services, Inc. | $11,438 | 7.0% |
| Biomedical Enterprises, Inc. | $1,091 | 0.7% |
| Synthes USA Products LLC | $540 | 0.3% |